Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography

[1]  J. Schulz-Menger,et al.  Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. , 2010, European journal of radiology.

[2]  H. Arheden,et al.  An automatic method for quantification of myocardium at risk from myocardial perfusion SPECT in patients with acute coronary occlusion , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[3]  Einar Heiberg,et al.  Design and validation of Segment - freely available software for cardiovascular image analysis , 2010, BMC Medical Imaging.

[4]  M. Friedrich,et al.  Single‐shot steady‐state free precession can detect myocardial edema in patients: A feasibility study , 2009, Journal of magnetic resonance imaging : JMRI.

[5]  Einar Heiberg,et al.  Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. , 2009, JACC. Cardiovascular imaging.

[6]  Joseph V Hajnal,et al.  Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. , 2009, Radiology.

[7]  Einar Heiberg,et al.  An Improved Method for Automatic Segmentation of the Left Ventricle in Myocardial Perfusion SPECT , 2009, Journal of Nuclear Medicine.

[8]  Einar Heiberg,et al.  Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction Zone: One-Year Follow-Up by MRI , 2009, Circulation. Cardiovascular imaging.

[9]  Marcus Carlsson,et al.  Magnetic resonance imaging as a potential gold standard for infarct quantification. , 2008, Journal of electrocardiology.

[10]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[11]  J. Schulz-Menger,et al.  The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[12]  Einar Heiberg,et al.  Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. , 2008, Radiology.

[13]  Peter Kellman,et al.  ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.

[14]  Christopher E. Buller,et al.  2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.

[15]  Christopher E. Buller,et al.  2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Journal of the American College of Cardiology.

[16]  Andrew E Arai,et al.  In Vivo T2-Weighted Magnetic Resonance Imaging Can Accurately Determine the Ischemic Area at Risk for 2-Day-Old Nonreperfused Myocardial Infarction , 2008, Investigative radiology.

[17]  J. Goldfarb,et al.  Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. , 2007, Radiology.

[18]  Daniel C. Lee,et al.  Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. , 2007, European heart journal.

[19]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[20]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Feasibility and Initial Experience of Assessment of Mechanical Dyssynchrony Using Cardiovascular Magnetic Resonance and Semi-automatic Border Detection , 2008 .

[21]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[22]  R. F. Hoyt,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[23]  J. Serfaty,et al.  Value of contrast‐enhanced, balanced cine‐MR sequences in the assessment of apparent infarct size after acute myocardial infarction: A prospective comparison with delayed‐enhancement sequences , 2005, Journal of magnetic resonance imaging : JMRI.

[24]  R. Gibbons,et al.  Feasibility of Tomographic 99 mTc-Hexalis-2-Methoxy-2-Methylpropyl-Isonitrile Imaging for the Assessment of Myocardial Area at Risk and the Effect of Treatment in Acute Myocardial Infarction , 2005 .

[25]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[26]  R. Kloner,et al.  Cardiac protection during acute myocardial infarction: where do we stand in 2004? , 2004, Journal of the American College of Cardiology.

[27]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[28]  S. Nekolla,et al.  Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis , 2003, Circulation.

[29]  L. Rydén,et al.  Pharmacological possibilities for protection against myocardial reperfusion injury. , 2002, Cardiovascular research.

[30]  Fibrinolytic Therapy Trialists' Collaborative Group.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.

[31]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[32]  W. Wijns,et al.  Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. , 1990, Circulation.

[33]  D D Watson,et al.  Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. , 1990, Circulation.

[34]  R. Gibbons,et al.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. , 1989, Circulation.

[35]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[36]  R. Jennings,et al.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. , 1979, Laboratory investigation; a journal of technical methods and pathology.